StonvexLoading…
StonvexStonvexStonvexCore line items from MGNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $149.50M | $149.96M | $58.75M | $151.94M |
Operating Income | $-72.84M | $-110.58M | $-168.24M | $-121.42M |
Net Income | $-74.62M | $-66.97M | $-9.06M | $-119.76M |
EPS (Diluted) | $-1.18 | $-1.07 | $-0.15 | $-1.95 |
Total Assets | $256.85M | $261.65M | $298.42M | $280.47M |
Total Liabilities | $201.25M | $145.60M | $145.81M | $138.46M |
Cash & Equivalents | $57.22M | $182.84M | $100.96M | $108.88M |
Free Cash Flow OCF − CapEx | $-82.95M | $-72.08M | $-79.97M | $-90.58M |
Shares Outstanding | 63.32M | 62.82M | 62.07M | 61.70M |